What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially announce and provide access to Merck & Co., Inc.'s financial results for the third quarter of 2015. It incorporates by reference the company's earnings press release and supplemental financial information.

Where can I find the detailed financial information for Merck's Q3 2015 results?

The detailed financial information is not directly included in the 8-K form itself. Investors need to refer to Exhibit 99.1 (the press release issued October 27, 2015) and Exhibit 99.2 (certain supplemental information) which are incorporated by reference in the filing.

Does this filing contain any new financial guidance from Merck?

This 8-K filing is primarily to report past results. Any new financial guidance or forward-looking statements would be contained within the incorporated press release (Exhibit 99.1) or supplemental information (Exhibit 99.2). Investors should carefully review these documents for such details.

What does it mean that the information is 'furnished' and not 'filed' under Section 18?

When information is furnished under Item 2.02, it means it is being provided to the SEC for informational purposes but is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This typically means the information is not subject to the same liabilities related to fraud or misstatement under that specific section, although it's still important for investors to consider.

MRK 8-K: Earnings & Results

Summary

Merck & Co., Inc. (MRK) filed a Form 8-K on October 27, 2015, to report its financial results for the third quarter of 2015. The filing primarily incorporates by reference a press release (Exhibit 99.1) and supplemental financial information (Exhibit 99.2) detailing the company's performance during the period. Investors should review these attached documents for specific financial figures, operational highlights, and management commentary on the quarter's results. While the 8-K itself does not contain the detailed financial data, its purpose is to officially disseminate the company's quarterly earnings announcement. The incorporated exhibits are crucial for understanding Merck's revenue, earnings per share, key product performance, and any forward-looking statements or guidance provided by the company. This filing serves as the official notification of Merck's Q3 2015 financial outcomes.

Key Highlights

1Merck & Co., Inc. filed an 8-K on October 27, 2015, to report its third-quarter 2015 financial results.
2The filing incorporates by reference a press release dated October 27, 2015, detailing Q3 2015 earnings.
3Supplemental financial information not included in the press release is also incorporated by reference.
4Investors should refer to the attached exhibits (99.1 and 99.2) for specific financial details and operational performance.
5This report officially disseminates Merck's Q3 2015 earnings announcement.
6The information provided is intended to update investors on the company's financial condition and results of operations.
7The filing falls under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Merck & Co., Inc. 8-K Report, Financial Results (Oct 27, 2015)

Summary

Key Highlights

Frequently Asked Questions